Inari Medical Shares Outstanding 2019-2023 | NARI
Inari Medical shares outstanding from 2019 to 2023. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Inari Medical Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023 | 57 |
| 2022 | 53 |
| 2021 | 56 |
| 2020 | 52 |
| 2019 | 6 |
| 2018 | 5 |
| Inari Medical Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2023-12-31 | 57 |
| 2023-09-30 | 59 |
| 2023-06-30 | 58 |
| 2023-03-31 | 55 |
| 2022-12-31 | 53 |
| 2022-09-30 | 53 |
| 2022-06-30 | 53 |
| 2022-03-31 | 51 |
| 2021-12-31 | 56 |
| 2021-09-30 | 50 |
| 2021-06-30 | 56 |
| 2021-03-31 | 56 |
| 2020-12-31 | 52 |
| 2020-09-30 | 55 |
| 2020-06-30 | 24 |
| 2020-03-31 | 45 |
| 2019-12-31 | |
| 2019-09-30 | 44 |
| 2019-06-30 | 6 |
| 2018-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $2.732B | $0.494B |
| Inari Medical, Inc. is a commercial-stage medical device company committed toward developing products to treat and change the lives of patients suffering from venous diseases. Its initial product offering comprises 2 minimally-invasive, novel catheter-based mechanical thrombectomy devices. It built its products purposely on the basis of the specific characteristics of the venous system and the treatment of the two distinct indications of venous thromboembolism or VTE (deep vein thrombosis and pulmonary embolism/ PE). Its FlowTriever product is the first thrombectomy system, which is FDA-cleared, used for the treatment of PE. Its advanced systems & processes to control the key relationships between its sales representatives and treating physicians like cardiologists, radiologists, helps it to quickly iterate products, launch and execute physician education and training programs and scale its sales organization. The company markets and sells its products to hospitals across the U.S. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $228.656B | 27.71 |
| Intuitive Surgical (ISRG) | United States | $141.664B | 85.34 |
| Edwards Lifesciences (EW) | United States | $54.330B | 35.36 |
| DexCom (DXCM) | United States | $51.584B | 78.14 |
| IDEXX Laboratories (IDXX) | United States | $45.302B | 53.10 |
| Alcon (ALC) | Switzerland | $44.364B | 31.79 |
| IQVIA Holdings (IQV) | United States | $42.578B | 24.70 |
| STERIS (STE) | Ireland | $23.267B | 27.19 |
| Waters (WAT) | United States | $21.461B | 31.54 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.656B | 0.00 |
| Hologic (HOLX) | United States | $17.471B | 19.55 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $13.151B | 15.35 |
| ShockWave Medical (SWAV) | United States | $12.422B | 77.31 |
| Sysmex ADR (SSMXY) | Japan | $11.022B | 34.56 |
| Teleflex (TFX) | United States | $10.353B | 16.11 |
| Globus Medical (GMED) | United States | $8.736B | 25.61 |
| Penumbra (PEN) | United States | $7.935B | 90.18 |
| Masimo (MASI) | United States | $6.166B | 35.52 |
| Glaukos (GKOS) | United States | $5.610B | 0.00 |
| TransMedics (TMDX) | United States | $4.484B | 425.44 |
| Integer Holdings (ITGR) | United States | $3.944B | 23.83 |
| PROCEPT BioRobotics (PRCT) | United States | $3.558B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.422B | 20.32 |
| Tandem Diabetes Care (TNDM) | United States | $3.060B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.923B | 20.05 |
| Nihon Kohden (NHNKY) | Japan | $2.428B | 20.53 |
| RxSight (RXST) | United States | $2.378B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $2.086B | 9.10 |
| Veracyte (VCYT) | United States | $1.800B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.604B | 0.00 |
| Artivion (AORT) | United States | $0.990B | 94.92 |
| OPKO Health (OPK) | United States | $0.941B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.919B | 17.88 |
| Silk Road Medical (SILK) | United States | $0.854B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.748B | 0.00 |
| Paragon 28 (FNA) | United States | $0.672B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.640B | 21.72 |
| SiBone (SIBN) | United States | $0.623B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.584B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.575B | 0.00 |
| IRadimed (IRMD) | United States | $0.534B | 29.89 |
| Pulse Biosciences (PLSE) | United States | $0.401B | 0.00 |
| Nevro (NVRO) | United States | $0.388B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.369B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.325B | 11.13 |
| Sight Sciences (SGHT) | United States | $0.276B | 0.00 |
| AxoGen (AXGN) | United States | $0.260B | 0.00 |
| NeuroPace (NPCE) | United States | $0.260B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.255B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.255B | 0.00 |
| 908 Devices (MASS) | United States | $0.250B | 0.00 |
| Inogen (INGN) | United States | $0.208B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.202B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.200B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.185B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.175B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| Accuray (ARAY) | United States | $0.168B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.167B | 8.49 |
| Yubo Biotech (YBGJ) | China | $0.109B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.107B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.103B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.101B | 21.17 |
| Neuronetics (STIM) | United States | $0.073B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.067B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.065B | 0.00 |
| Hyperfine (HYPR) | United States | $0.063B | 0.00 |
| SEP Acquisition (SEPA) | United States | $0.060B | 0.00 |
| Envoy Medical (COCH) | United States | $0.059B | 0.00 |
| InspireMD (NSPR) | Israel | $0.057B | 0.00 |
| DarioHealth (DRIO) | United States | $0.055B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.051B | 0.00 |
| LENSAR (LNSR) | United States | $0.047B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.045B | 0.00 |
| ReWalk Robotics (LFWD) | Israel | $0.043B | 0.00 |
| Precision Optics (POCI) | United States | $0.040B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.036B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.035B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.034B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.033B | 0.00 |
| Spectral AI (MDAI) | United States | $0.029B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.025B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.020B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.019B | 0.00 |
| PAVmed (PAVM) | United States | $0.018B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.014B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.013B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.013B | 0.00 |
| Avinger (AVGR) | United States | $0.006B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.004B | 0.00 |
| Tenon Medical (TNON) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Dynatronics (DYNT) | United States | $0.002B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |